Eagle Pharmaceuticals' Series C Round

Eagle Pharmaceuticals raised a round of funding on February 18, 2011.

Eagle Pharmaceuticals (NASDAQ:EGRX) is a specialty pharmaceutical company focused on developing and commercializing injectable products utilizing the FDA's 505(b)(2) regulatory pathway. The company de…

Articles about Eagle Pharmaceuticals' Series C Round: